We are live on !
Find out more
RCI
Ridgeback Capital Investments Portfolio holdings
AUM
$80.9M
This Fund
S&P 500
This Quarter Est. Return
+44.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$80.9M
AUM Growth
–
Cap. Flow
+$44.7M
Cap. Flow % of AUM
Cap. Flow %
55.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Replimune Group
REPL
|
+$44.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Replimune Group
REPL
$1.67B
| $80.9M | 100% |
+7,310,656
| New | +$44.7M |
2026 Q2
0 quarters
|
|
Similar funds
NVIM
BG
Ridgeback Capital Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Ridgeback Capital Investments held 1 position worth $80.9M. Its ten largest holdings account for 100% of the portfolio.
Ridgeback Capital Investments deployed $44.7M of net new capital in Q2 2026, opening 1 new position. Its largest new stake was Replimune Group: 7,310,656 shares worth $80.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Ridgeback Capital Investments's largest Q2 2026 buy was Replimune Group: 7,310,656 shares worth $80.9M.
- Ridgeback Capital Investments's ten largest holdings make up 100% of its $80.9M portfolio in Q2 2026.
- Ridgeback Capital Investments opened 1 new position and closed 0 in Q2 2026.
Based on Ridgeback Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.